RUXOLITINIB COMPARED WITH BEST AVAILABLE THERAPY FOR ESSENTIAL THROMBOCYTHAEMIA PATIENTS RESISTANT OR INTOLERANT TO HYDROXYCARBAMIDE IN MAJIC - AN INVESTIGATOR LEAD RANDOMIZED TRIAL

Claire Harrison, Andrew Mead, Amey C Panchal, Stephen B. Fox, Christina Yap, Aimee E. Houlton, Samah Aliman, Michelle Wood, F Chen, Jason Coppell, Nicki Panoskaltsis, R. Scherber, Holly L. Geyer, Amylou C. Dueck, Ruben A. Mesa, M. F. McMullin
Oxford University Research Archive (ORA) (University of Oxford)
January 1, 2016
Cited by 1Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis